Castle Scott M, Gorbatiy Vladislav, Leveillee Raymond J
Department of Urology, Division of Endourology, Miller School of Medicine, University of Miami, 1400 NW 10th Ave, Ste 509, Miami, FL, 33136, USA.
J Robot Surg. 2011 Sep;5(3):209-14. doi: 10.1007/s11701-011-0262-y. Epub 2011 Mar 20.
Partial nephrectomy is the current gold-standard treatment of small renal masses. The articulated instruments of the surgical robot have made the laparoscopic approach more feasible. We present our experience with 50 robot-assisted laparoscopic partial nephrectomy (RALPN) surgeries and attempt to validate a recently reported nephrometry score. From July 2008 to July 2010, 50 (53 planned) elective RALPNs were performed utilizing the da Vinci Surgical System (Intuitive Surgical, Sunnyvale, CA, USA). All patients had an enhancing renal mass on CT scan pre-operatively. Clinicopathologic, surgical, and renal functional (Cockcroft-Gault formula) outcomes were recorded prospectively and analyzed. Mean tumor size, length of surgery (LS), warm ischemia time (WIT), and nephrometry scores were 3.6 cm (1-8), 303 min (133-610), 29.1 min (11-42), and 6.8 (4-11) respectively. Renal cell carcinoma was found in 39 (78%) patients. When evaluating the nephrometry score, comparison of low, medium, and high complexity tumors for length of surgery, WIT, and estimated blood loss (EBL) showed no difference (p > 0.05). Nearness to the collecting system (N score 1 vs. N score 3) showed increased EBL (195 ml vs. 510 mL, p = 0.005), and location relative to polar lines (L score 1 and L score 2) increased mean LS (265 vs. 359 min, p = 0.02). RALPN is safe and effective. Nephrometry scores are a method of standardizing tumor complexity and can be utilized in comparing tumor cohorts but may not be predictive of intra-operative outcomes.
肾部分切除术是目前治疗小肾肿块的金标准疗法。手术机器人的关节器械使腹腔镜手术方法更具可行性。我们介绍了50例机器人辅助腹腔镜肾部分切除术(RALPN)的手术经验,并试图验证最近报道的肾计量评分。2008年7月至2010年7月,使用达芬奇手术系统(直观外科公司,美国加利福尼亚州森尼韦尔)进行了50例(计划53例)择期RALPN手术。所有患者术前CT扫描均显示有强化的肾肿块。前瞻性记录并分析临床病理、手术及肾功能(Cockcroft-Gault公式)结果。平均肿瘤大小、手术时长(LS)、热缺血时间(WIT)及肾计量评分分别为3.6 cm(1 - 8)、303分钟(133 - 610)、29.1分钟(11 - 42)及6.8(4 - 11)。39例(78%)患者为肾细胞癌。在评估肾计量评分时,低、中、高复杂性肿瘤在手术时长、WIT及估计失血量(EBL)方面的比较无差异(p > 0.05)。与集合系统的接近程度(N评分1与N评分3)显示EBL增加(195 ml对510 ml,p = 0.005),相对于极线的位置(L评分1和L评分2)使平均LS增加(265对359分钟,p = 0.02)。RALPN安全有效。肾计量评分是一种标准化肿瘤复杂性的方法,可用于比较肿瘤队列,但可能无法预测术中结果。